Cencora Price Target Raised to $429 as BI Asset Management Increases Stake 17.9%
Wells Fargo maintained an Overweight rating on Cencora and raised its price target from $405 to $429. BI Asset Management boosted its position by 17.9%, now holding 144,287 shares valued at approximately $45 million.
1. Wells Fargo Overweight Rating and Price Target Increase
Wells Fargo maintained an Overweight rating on Cencora and raised its price target from $405 to $429, reflecting confidence in the company’s pharmaceutical distribution network and future growth prospects.
2. BI Asset Management Raises Holdings by 17.9%
BI Asset Management Fondsmaeglerselskab A S boosted its position by 17.9%, purchasing 21,933 shares to reach a total of 144,287 shares valued at approximately $45 million, representing roughly 0.07% of Cencora’s market value.
3. Stock Volatility and Market Capitalization
Cencora shares traded between $358.94 and $367.28 today, up 1.119%, with a year-to-date high of $377.54 and low of $237.71. The company’s market capitalization stands near $70.67 billion, with daily trading volume around 946,209 shares.